Johnson & Johnson Yields 2.17% with 6.95% Projected EPS Growth to $11.54
Johnson & Johnson currently yields 2.17% by paying $1.30 per share quarterly ($5.20 annualized), exceeding the Large Cap Pharmaceuticals industry yield of 1.75% and the S&P 500's 1.34%. Analysts project 2026 EPS at $11.54, a 6.95% gain from 2025, supporting further dividend increases given a 48% payout ratio.
1. Dividend Yield Profile
Johnson & Johnson pays $1.30 per share quarterly, translating to a 2.17% yield that outpaces the Large Cap Pharmaceuticals industry average of 1.75% and the S&P 500's 1.34%.
2. Consistent Dividend Growth
The company’s annualized dividend rose 1.2% year-over-year to $5.20, reflecting an average 5.37% annual increase over five years while maintaining a 48% payout ratio of trailing EPS.
3. Earnings Outlook Supports Payout
Analysts forecast 2026 EPS of $11.54, representing 6.95% growth from last year and indicating capacity for continued dividend hikes under the current payout ratio.